Lumos Networks Corp. (NASDAQ:LMOS) traded 106886 shares and was closed at $14.06 per share. The current share price indicates that stock is -4.42% away from its one year high and is moving 38.11% ahead of its one year low. Stock monthly performance is recorded as -2.70% while its performance in last 5 sessions is -1.54%.
Analyst’s Analysis on Lumos Networks Corp. (NASDAQ:LMOS)
At the movement stock is under coverage by number of analysts. no analyst given UNDERPERFORM rating to the stock whereas 2 analysts think that it is worth to BUY this stock and no analyst given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Buy and their mean rating for the stock is 1.33 on scale of 1-5. Analysts mean target price for Lumos Networks Corp. (NASDAQ:LMOS) is $17.38 while their mean recommendation is 1.30 (1=Buy, 5=sell).
Lumos Networks Corp. (NASDAQ:LMOS) is now offering SecurityCoverage’s Tech Home managed solutions to the more than 18,000 residences passed by the Company’s advanced fiber footprint. Lumos’ Gigabit FAST fiber service offerings, with internet speed up to One Gigabit per second, is available to all of these 18,000 residences. Tech Home managed solutions provide a unique combination of Internet & data security software, cloud backup, and 24|7 premium technical support for most Connected Home and Consumer Electronic (CE) devices. Tech Home is available in three different levels to meet the varying needs of consumers based on the quantity of devices in their home and the desired level of support.
Diplomat Pharmacy, Inc. (NYSE:DPLO) shares moved to $22.77 after starting the day at $24.17 on Friday. Weekly volatility of DPLO is 5.36% and monthly volatility is 3.35%. Stock performance in last five sessions is recorded as -21.10% while year to date (YTD) performance is -33.46%. DPLO Gross Margin is 7.80% and its return on assets is 4.20%. Stock 3 months performance is recorded as -36.25%.
Analyst Rating on Diplomat Pharmacy, Inc. (NYSE:DPLO)
Number of analysts are covering this stock and currently stock has got OUTPERFORM rating from 2 analysts of Thomson Reuters, 7 analysts given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for DPLO is $36.20 while analysts mean recommendation is 2.20.
Diplomat Pharmacy, Inc. (NYSE:DPLO) has announced that Phil Hagerman, Chairman & CEO, and Sean Whelan, CFO, will present at the upcoming 25th Annual Credit Suisse Healthcare Conference in Scottsdale, Arizona. Mr. Hagerman and Mr. Whelan are scheduled to present at the conference on Tuesday, November 8, 2016 at 4:00 PM MT.
